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CASE PRESENTATION
A 41-year-old white man presented with a 6-month
history of worsening neck pain accompanied by 20 lb
weight loss. He was initially referred to an orthopedic
surgeon and work-up including magnetic resonance
imaging revealed shoulder bursitis for which he received a
steroid injection. However, neck pain continued and
laboratory tests revealed anemia and renal insufficiency,
leading to his referral to an internist. The patient had no
significant past medical history or family history of renal
disease and he was not taking any medications. Physical
examination revealed temporal wasting but was
otherwise unremarkable. Laboratory investigations
revealed the following: blood urea nitrogen 32 mg/dl
(normal 7–25 mg/dl), serum creatinine 4.2 mg/dl
(normal 0.5–1.4 mg/dl), serum calcium 9.8 mg/dl
(normal 8.5–10.4 mg/dl), phosphorous 4.3 mg/dl
(normal 2.5–4.5 mg/dl), sodium 143 mmol/l (normal
135–146 mmol/l), potassium 3.6 mmol/l (normal
3.5–5.3 mmol/l), chloride 109 mmol/l (normal
98–110 mmol/l), bicarbonate 17 mmol/l (normal
21–33 mmol/l), glucose 95 (normal 65–139 mg/dl), lactate
dehydrogenase 505 (normal 105–333 IU/l), white blood
cell count 9800/ml, hemoglobin 9.7 g/dl, hematocrit 28.3%,
and platelet count 316 000/ml. Erythrocyte sedimentation
rate was markedly elevated (4100 mm/h). Total serum
protein was 8.8 g/dl (normal 6.0–8.3 g/dl), serum albumin
was 4.2 g/dl (normal 3.5–4.9 g/dl), and b2-microglobulin
was elevated (10.7 mg/l, normalo1.85 mg/l). Quantitative
serum immunoglobulins (Ig) revealed elevated IgD (842
mg/dl, normal 0–14 mg/dl) and decreased levels of IgG
(450 mg/dl, normal 694–1618 mg/dl), IgA (32 mg/dl, nor-
mal 81–463 mg/dl), and IgM (9.9 mg/dl, normal 48–271 mg/
dl). Serum protein electrophoresis revealed a monoclonal
spike (0.82 g/dl) with IgD kappa (k) specificity, elevated
free k light chains (81 200 mg/l, normal range
3.3–19.4 mg/l), and normal level of lambda (l) light chains
(10.6 mg/l, normal range 5.7–26.3 mg/l). Urinalysis
revealed 100 mg/dl glucose; these findings, together with
the normal serum glucose, normal serum phosphate, and
low serum bicarbonate levels, suggested partial Fanconi’s
syndrome. Urinalysis also revealed 1þprotein; however,
24-h urine collection contained 20.2 g protein of which
13.975 g (69.2%) consisted of free k light chains. Bone
marrow examination revealed diffuse infiltration by
IgD k-positive plasma cells, accounting for 50% of overall
cellularity, consistent with multiple myeloma. Based on
the finding of significant urinary light chain excretion, the
patient’s multiple myeloma was stage III-B. A skeletal
survey revealed no bony lesions, and magnetic resonance
imaging of the axial skeleton revealed marrow
abnormalities consistent with myeloma but no osseous
lesions. Given the new onset of renal insufficiency
and partial Fanconi’s syndrome with massive urinary
light chain excretion, a renal biopsy was performed to
determine the pattern of dysproteinemia-related
renal disease.
Pathologic findings
Light microscopic examination revealed 12 glomeruli, two of
which were globally sclerotic. The non-sclerotic glomeruli
showed moderate hypertrophy and mild mesangial hyper-
cellularity and accumulations of matrix. No mesangial
nodules were seen. Glomerular basement membranes showed
segmental duplication with cellular interposition but most
peripheral capillary lumina were patent. Tubules contained
fractured, intensely eosinophilic casts that stained weakly or
negative with periodic acid-Schiff and showed polychro-
matic (blue–red) staining with trichrome stain, and were
surrounded by mononuclear cells and focal multinucleate
cells (Figure 1). Proximal tubules demonstrated widespread
degenerative and regenerative changes, including cyto-
plasmic simplification, nuclear enlargement, and prominent
nucleoli. Proximal tubular epithelial cells (Figure 2) and
interstitial cells (Figure 3) contained abundant needle-shaped
eosinophilic intracytoplasmic crystalline inclusions. The
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interstitial cells stained with the immunohistochemical
marker CD68, confirming their histiocytic origin (Figure 4).
Severe tubular atrophy and interstitial fibrosis were noted,
accompanied by a patchy mononuclear inflammatory cell
infiltrate. Arterial vessels showed moderate medial sclerosis
and intimal fibrosis. Congo Red stain was negative for
amyloid.
Immunofluorescence microscopy performed on frozen
tissue revealed intense (3þ ) staining of the atypical tubular
casts for k light chain only. Interstitial histiocytes and tubular
epithelial cells showed 2þ cytoplasmic staining for k light
chain. In addition, there was diffuse 2þ linear staining of
glomeruli, tubular basement membranes, and perimyocyte
basement membranes for k light chain. There was no specific
staining of glomeruli, tubular basement membranes, inter-
stitium, or vessels for IgG, IgA, IgM, C3, C1, fibrinogen,
albumin, or l light chain.
Electron microscopy revealed needle-shaped and rhomboid
intracytoplasmic inclusions in interstitial histiocytes and
proximal tubular epithelium (Figure 5), but not in podocytes
or other glomerular cells. These inclusions were mostly
electron dense, with focal areas of electron lucency, but did
not show a periodic substructure. In some areas, the inclusions
were associated with a single unit membrane (Figure 6).
Tubules contained amorphous electron dense casts. No
fibrillar, granular, or immune type electron densities were
seen. Podocytes showed minimal foot process effacement.
No histiocyte aggregates were seen by light microscopy in
the bone marrow biopsy and no electron microscopy was
performed.
Figure 1 | Fractured, eosinophilic cast (myeloma cast) surrounded
by mononuclear cells (arrow) (hematoxylin and eosin stain;
original magnification  600).
Figure 2 | Tubular epithelium displays eosinophilic
needle-shaped intracytoplasmic crystalline inclusions (arrow)
(hematoxylin and eosin stain; original magnification  1000).
Figure 3 | Numerous interstitial cells display eosinophilic
needle-shaped intracytoplasmic crystalline inclusions
(hematoxylin and eosin stain; original magnification  1000).
Figure 4 | Interstitial cells stain for CD68 confirming histiocytic
phenotype. Some of these cells display intracytoplasmic crystals
(arrow) (immunoperoxidase stain, original magnification  600).
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Pathologic diagnosis
1. Light chain cast nephropathy (LCCN), k type.
2. Light chain Fanconi’s syndrome (LCFS), k type
3. Crystal-storing histiocytosis (CSH).
The findings of fractured crystalline tubular casts staining for
k light chain and surrounded by mononuclear inflammatory
cells were diagnostic of LCCN, k type. The presence of
numerous, needle-shaped crystalline inclusions staining
for k light chain within proximal tubular epithelium,
together with the clinical evidence of tubular dysfunction
(low serum bicarbonate and glycosuria, with normal blood
glucose), was consistent with LCFS, whereas the finding of
numerous crystal-laden interstitial histiocytes indicated renal
involvement by CSH.
Follow-up
The patient was treated initially with pulse dexamethasone,
followed by a combination of pulse dexamethasone, thalido-
mide 200 mg/day, and bortezomib 1.5 mg/m2 in a standard
administration regimen. The patient also received monthly
zoledronate, allopurinol, furosemide, sodium bicarbonate, and
erythropoietin. Following one cycle of chemotherapy, serum
creatinine had declined to 2.4 mg/dl and urinary protein
excretion had decreased to 2.2 g/day, with trace urine
monoclonal component and free k light chains detected by
immunofixation. Repeat serum protein electrophoresis and
immunofixation revealed no monoclonal IgD component and
markedly reduced free k light chains 23 mg/dl (normal range
3.3–19.4 mg/l). A repeat bone marrow biopsy performed after 4
months showed no evidence of residual plasma cell myeloma.
Five months following the diagnosis of myeloma, the patient
underwent autologous stem cell transplantation conditioned by
melphalan 200 mg/m2, followed 4 months later by low-dose
total body irradiation and allogeneic peripheral blood stem cell
transplantation from a human leukocyte antigen-identical
sibling. Post-transplant immunosuppression consisted of
cyclosporine 400 mg b.i.d and mycophenolate mofetil
1250 mg b.i.d. At last follow-up (2 months post-allogeneic
peripheral blood stem cell transplantation and 11 months post-
renal biopsy), serum bicarbonate was 22 mg/dl (normal
21–33 mmol/l) and urinalysis was negative for glucose,
indicating improvement of Fanconi’s syndrome. However,
serum creatinine remained elevated at 2.2 mg/dl.
DISCUSSION
Dysproteinemia, characterized by synthesis of a monoclonal
Ig by neoplastic B lymphocytes, is associated with diverse
forms of kidney disease including several that are related to
precipitation or deposition of monoclonal Ig in the form of
casts, fibrils, granular deposits, or crystals.1 The commonest
form of nephropathy disease in myeloma patients with acute
renal failure is LCCN, also known as myeloma cast
nephropathy, characterized by crystalline intratubular casts
composed of monoclonal k or l light chain, together with
Tamm-Horsfall protein. Fibrillar Ig deposits occur in light
chain amyloidosis (AL) and amorphous granular deposits are
seen in monoclonal immunoglobulin deposition disease.2
Less commonly, monoclonal Ig forms intracellular crystals
within the cytoplasm of infiltrating neoplastic plasma
cells, histiocytes, or renal epithelial cells, or forms massive
extracellular crystalline deposits in Bowman space, inter-
stitium, or within blood vessels.3–6 The present case displayed
an unusual combination of morphologic findings that has
not been described previously in myeloma-associated
nephropathy, namely LCCN with coexistent intracytoplasmic
crystalline Ig deposits within interstitial histiocytes and
proximal tubular epithelial cells.
Figure 5 | Electron microscopy demonstrates rod-shaped and
rhomboid-shaped intracytoplasmic crystalline inclusions within
tubular epithelium (electron micrograph; original magnification
 4000).
Figure 6 | Tubular epithelium contains intracytoplasmic
rhomboid-shaped electron-dense crystalline structures, focally
accompanied by a unit membrane (arrow) (electron micrograph;
original magnification  12 000).
Kidney International (2006) 70, 597–602 599
MB Stokes et al.: Dysproteinemia-related nephropathy associated with CSH t h e r e n a l c o n s u l t
Intracytoplasmic crystalline Ig deposits may occur in
proximal tubular epithelial cells, infiltrating neoplastic
plasma cells, interstitial histiocytes, and glomerular epithelial
cells. Proximal tubular Ig crystals, usually of k light chain, are
associated with LCFS and clinical signs of tubular dysfunc-
tion including glycosuria, aminoaciduria, hypophosphate-
mia, metabolic acidosis, and renal insufficiency.1 In rare
LCFS patients with coexistent LCCN, as in the present case,
the clinical presentation is usually dominated by acute renal
failure. Crystalline Ig deposits occur within the cytoplasm of
interstitial histiocytes in CSH, a rare complication of multiple
myeloma or other lymphoproliferative disorders showing
plasmacytic differentiation including plasma cell granuloma
or extramedullary plasmacytoma.7–12 CSH usually involves
the bone marrow but may also involve extramedullary sites,
including cornea and kidney.7,13,14
In addition to the present case, nine previous case reports
described dysproteinemia-related nephropathy with renal
interstitial infiltration by Ig crystal-containing histiocytes
(Table 1).7,10,13,15–20 Nine patients had multiple myeloma and
one had multiorgan involvement by immunocytoma.7 Eight
of these 10 subjects also had crystal-containing cells in bone
marrow (involving either histiocytes or neoplastic plasma
cells). Seven patients had acute renal failure, and renal
function status for the other three individuals was not
provided.7,10 All 10 cases were associated with a k-containing
serum paraprotein (IgG k, seven; IgA k, two; IgD k, one)
and nine also displayed k Bence–Jones proteinuria. Eight
cases showed intracytoplasmic crystals within other
renal cells besides interstitial histiocytes, including tubular
epithelium,13,16–20 visceral epithelial cells,13,15–19 and parietal
epithelial cells;16,17 two cases described crystals within
mesangial cells and glomerular endothelial cells.13,16 In two
cases, renal infiltration by neoplastic plasma cells was
identified,15,17 including one subject who also showed
AL amyloid deposits in other organs, but not in the
kidney.17 In addition to the present case, two other patients
displayed atypical crystalline casts consistent with coexistent
LCCN.17,19 Nine patients received therapy for the hemato-
logic malignancy that included chemotherapy in seven,
prednisone only in one, and autologous stem cell transplan-
tation in three. Six patients died (from 7 to 60 months
post-diagnosis) and four had stable renal function following
therapies that included autologous stem cell transplantation
and chemotherapy.
Several additional case reports have described nephro-
pathy with crystalline Ig involving renal cells other than
interstitial histiocytes. In one patient who developed renal
failure in the setting of CSH and multiple myeloma
crystalline Ig deposits were confined to Bowman’s space.
Hirota et al.5 described a case of multiple myeloma and AL
amyloidosis with Bence –Jones l light chain proteinuria,
with features of LCCN, renal amyloidosis, and extracellular l
crystals that localized in the vicinity of Bowman’s capsule
and vessels and Truong et al.21 described a case of multiple
myeloma with l LCFS and massive renal infiltration by
crystal-laden neoplastic plasma cells. In one case associated
with a low-grade B-cell lymphoproliferative disorder, renal
involvement was limited to mesangial infiltration by crystal-
laden histiocytes.12 One other report described a patient with
benign monoclonal gammopathy and nephrotic syndrome
whose renal biopsy showed crystalline Ig predominantly
involving podocytes, with focal involvement of parietal
epithelial cells and distal tubular epithelial cells.22
Most cases with renal crystalline Ig deposits are associated
with multiple myeloma and Bence–Jones proteinuria, sug-
gesting that the filtered load of paraprotein might be an
important determinant of renal Ig crystallogenesis. This
interpretation is supported by the observation that 60% of
patients with renal crystal-laden interstitial histiocytes
also display visceral epithelial cell crystals. The presence of
interstitial histiocytes in these cases is presumably a reaction
to leakage of filtered k paraprotein via damaged or over-
burdened tubules. However, the relative rarity of renal
crystalline Ig deposition in patients with multiple myeloma
and Bence–Jones proteinuria implies that other factors
besides filtered Ig load must play a role. These factors
likely include inherent physicochemical properties related to
Table 1 | Dysproteinemia-related nephropathy associated with crystal-containing interstitial histiocytes
Paraprotein Location of crystal-containing cells
AuthorRef. Age/sex Serum Urine
Renal
failure
Bone
marrow Glomerulus TE Histiocyte
Atypical
casts Other Diagnosis
Takahashi et al.15 60/m IgA k k Yes H VEC U Yes No MM cells MM–AL–CSH
Carstens and Woo16 57/m IgG k Yes PC VEC; PEC; mes; endo Yes Yes No MM–renal CSH
Yamamoto et al.17 71/m IgG k k Yes PC; H VEC; PEC Yes Yes Yes MM cells MM–CSH–LCCN
Garcia et al.7 44/m IgG k None U H No No Yes No Immunocytoma–CSH
Lebeau et al.10 73/m IgA k k U PC; H No No Yes No MM–CSH
Keller et al.18 56/m IgG k k Yes Yes VEC Yes Yes No MM–CSH
Papla et al.13 51/m IgG k k U H VEC; endo; mes Yes Yes No MM–CSH
Tomioka et al.19 46/f IgG k k Yes PC; H VEC Yes Yes Yes MM–CSH–LCCN
Tholouli et al.20 62/f IgG k k Yes No No Yes Yes No MM–renal CSH
Present case 41/m IgD k k Yes No No Yes Yes Yes MM–renal CSH–LCCN
AL, light chain amyloidosis; BM, bone marrow; CSH, crystal-storing histiocytosis; endo, glomerular endothelial cell; f, female; FSGS, focal segmental glomerulosclerosis; H,
histiocyte; LCCN, light chain cast nephropathy; LCFS, light chain Fanconi’s syndrome; m, male; mes, mesangial cell; MM, multiple myeloma; MZL, marginal zone lymphoma;
PC, plasma cell; PEC, parietal epithelial cell; SRF, stable renal function; STTx, stem cell transplant; TE, tubular epithelial cell; U, unknown/not stated; VEC, visceral epithelial cell.
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the primary amino-acid sequence that influence protein
folding, resistance to proteolytic degradation, and inter-
actions with other molecules in the local environment, as
well as general environmental factors, such as dehydra-
tion and metabolic acidosis, that have been shown to
play a role in LCCN and other forms of dysproteinemia-
related Ig deposition.23
Most crystalline Ig deposits, including those seen in LCFS
and CSH, consist of k light chain deposits, strongly
suggesting that the light chain isotype is a major determinant
of crystallogenesis. The majority of light chains that crystal-
lize in the proximal tubules in LCFS belong to the Vk1
variability subgroup and most of these are encoded by the
LC02/012 germ line.24 In addition, these k light chains
frequently display an unusual hydrophobic residue in
position 30 of the V domain that may contribute to crystal
formation.25 Leboulleux et al.26 have shown that the crystals
in LCFS are resistant to proteolytic cleavage in vitro,
suggesting that crystal accumulation within lysosomes may
result from resistance to degradation. By analogy, the
persistence of crystals within histiocytes in CSH suggests
impaired degradation. Interestingly, in a recent case report
of CSH that later evolved to myeloma, Lebeau et al.10 also
identified Vk1 light chain with several unusual amino-acid
substitutions, some of which were previously described in
cases of AL amyloidosis. These findings support a common
pathomechanism in LCFS and CSH involving sequence
abnormalities at specific amino-acid sites in the k light
chain molecule that promote crystallogenesis or interfere
with intralysosomal degradation. No association with
specific Ig heavy chain subtype has been identified in
CSH.5 However, Papla et al.13 identified a biochemically
abnormal IgG k in a case of CSH, characterized by
abnormally high proteolytic susceptibility of the g heavy
chain and increased aggregation tendency that likely resulted
from its low structural stability.
Although the identity of k light chain in tubular
epithelium and interstitial histiocytes was not confirmed in
the present case, it seems reasonable to speculate that similar
mechanisms contributed to intracytoplasmic crystal forma-
tion in tubular epithelium and in interstitial histiocytes. The
unusual finding in the present case of coexistence of LCCN
with crystalline Ig deposits in interstitial histiocytes and
proximal tubular epithelium supports a major role for post-
synthetic handling of filtered monoclonal k light chain in
determining the localization of monoclonal Ig deposits
within renal subcompartments in dysproteinemia-related
nephropathy.
The prognostic significance of renal biopsy findings of
CSH is unknown. Interestingly, prolonged survival has been
reported in some myeloma patients with CSH, perhaps
reflecting earlier detection of hematologic disease owing to
organ involvement by crystal-laden cells.9 On the other hand,
renal involvement by CSH, particularly if accompanied
by signs of renal failure, may have a poor prognosis.9
Therapy should be directed at the underlying hematologic
malignancy. Although the presence of coexistent myeloma
cast nephropathy might be predicted to adversely affect
renal outcome, aggressive therapy of the underlying hema-
tologic disorder may stabilize renal function in patients
with renal CSH, as per the present case, presumably via
reduced synthesis and glomerular filtration of the pathogenic
light chain.
In summary, renal infiltration by histiocytes containing
crystalline Ig is a rare complication of dysproteinemia that
is usually associated with multiple myeloma, k light chain
Bence–Jones proteinuria, and bone marrow involvement
by CSH. Most cases also display Ig crystals in other renal
epithelial cells, and a minority display coexistent LCCN. The
renal presentation is usually dominated by acute renal failure
that is likely related to a combination of tissue infiltration
by crystal-laden histiocytes and acute tubular injury owing
to the presence of intracytoplasmic crystals and/or
LCCN. Despite the striking histologic injury, the findings of
coexistent myeloma cast nephropathy, LCFS, and renal CSH
do not necessarily portend a poor renal outcome. As this case
illustrates, aggressive therapy directed to the hematologic
malignancy can reverse the Fanconi’s syndrome and stabilize
renal function.
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